Kuva and Lisata Therapeutics Tender Offer Update
HOUSTON, TX, UNITED STATES, June 1, 2026 /EINPresswire.com/ -- As previously announced on May 29, 2026, Kuva Labs, Inc. (“Kuva” or “Parent”) and Lisata Therapeutics, Inc. (“Lisata”) (Nasdaq: LSTA), together with Kuva’s wholly owned subsidiary …